Fondaparinux is an anticoagulant medication used to prevent and treat blood clots. It is given by injection, usually once a day, and works by blocking the action of certain proteins involved in the body's clotting process. Fondaparinux is used to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) in adults, as well as to treat and prevent DVT in adults who have undergone knee or hip surgery. It can also be used to prevent clotting in patients with certain types of heart attack. Fondaparinux is not recommended for use in people with kidney failure or those who are allergic to it.
Fondaparinux, also known by the brand name Arixtra, is a medication used to prevent and treat blood clots [MedlinePlus: Fondaparinux Injection]. Here's a breakdown of its key features:
- Type of drug: Anticoagulant
- Function: Works by inhibiting Factor Xa, a protein involved in the clotting cascade, thereby reducing blood clotting [DrugBank: Fondaparinux]
- Uses:
- Prevents blood clots after certain surgeries, such as hip replacement or abdominal surgery [MedlinePlus: Fondaparinux Injection]
- Treats deep vein thrombosis (DVT) and pulmonary embolism (PE), which are blood clots in the leg and lung respectively [MedlinePlus: Fondaparinux Injection]
- Administration: Given as an injection under the skin (subcutaneous) in the lower abdomen area [MedlinePlus: Fondaparinux Injection]
Some additional points to note:
- Fondaparinux is different from blood thinners like warfarin as it targets a specific clotting factor and doesn't require regular blood monitoring [Wikipedia: Fondaparinux].
- There are potential side effects associated with fondaparinux, the most common being bleeding. It's crucial to discuss these risks and benefits with your doctor before using the medication [MedlinePlus: Fondaparinux Injection].
- Fondaparinux may also interact with other medications, so it's important to inform your doctor about all the medicines you're taking [Medscape: Arixtra (fondaparinux)].